Taken together, we suggest that IFNγ/STAT1 is the core of the critical gene regulatory network connecting the epithelial–immune crosstalk in rosacea development, and targeting IFNγ/STAT1 might be a potential therapy for the treatment of rosacea. Here, IFNG is linked to rosacea.